Fujifilm Healthcare unveils Synapse Pathology at the European Congress of Pathology: digital diagnosis reimagined

At the 36th European Congress of Pathology (ECP), Fujifilm Healthcare introduced Synapse Pathology, a cutting-edge solution for the digital transformation of anatomical pathology. With integrated artificial intelligence, the platform provides simplified workflows, faster diagnoses, and enhanced collaboration among specialists.

The importance of Synapse Pathology in digital diagnosis

Synapse Pathology is a comprehensive digital solution designed to support Pathology Departments with advanced reporting and integrated analysis features. The platform offers quick access to images and fosters multidisciplinary collaboration, improving efficiency in managing pathology cases.

The introduction of Synapse Pathology Gateway marks a significant advancement in digital transformation, enhancing interoperability between healthcare facilities and reducing diagnostic time.

Artificial intelligence at the service of healthcare

With its integrated AI, Synapse Pathology can process digital images 1.7 hours faster than traditional glass slides, enabling pathologists to consult and diagnose cases remotely. This technology not only accelerates diagnostic time but also improves the efficiency and quality of healthcare services.

Fujifilm Healthcare’s strategic collaborations

At the ECP event, Fujifilm Healthcare highlighted its collaborations with global leaders like Ibex and AWS. These partnerships reinforce the offering of innovative solutions for digital pathology and demonstrate the company’s commitment to improving healthcare workflows through advanced collaboration and diagnostic tools.